● Recruiting

Checkpoint Inhibitor-induced Liver Injury

Condition: Immune-Mediated Hepatitis · Sponsor: University of Nottingham

PhaseN/A

Planned participants160

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

In this multi-center prospective observational study, the investigators plan to identify the incidence and risk factors for checkpoint inhibitor-induced liver injury and characterize biochemical, genetic, immunological, and histological features associated with it.

This description comes directly from the study's public registry record.

Talk to the study team

Guruprasad Padur Aithal, MBBS, FRCP, PhD · 0115 823 1074 · guru.aithal@nottingham.ac.uk

Edmond Atallah, M.D, MRCP(UK) · edmond.atallah@nottingham.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

University of Nottingham

Nottingham, United Kingdom

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04476563